EUVIMEDEUVIMED entdecken
Crossref

A Robust Mitochondria‐Targeted Photosensitizer Synergizes With Cisplatin Chemotherapy for Enhanced Antitumor Immunity

Wudama Cui, Min Li, Qingqing Bai, Na Shun Meng He, Shun Yao, Yanhe An, Enyu Li, Xuebo Chen, Yajun Meng, Xinghua Wu, Duo Mao iD, Juan Wang und 1 weitere

Chemistry – A European Journal · 03.11.2026 · 32 (41)

DOI: 10.1002/chem.71531 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry – A European Journal, online erschienen am 13.08.2026. Verfasst von Wudama Cui und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Interventional Therapy, Peking University Cancer Hospital (Inner Mongolia Campus) & Affiliated Cancer Hospital of Inner Mongolia Medica…. Hauptthemen laut MEDLINE: Cisplatin, Photosensitizing Agents, Mitochondria, Antineoplastic Agents. Die Arbeit nennt 20 Literaturangaben. Gefördert von: Inner Mongolia Natural Science Fund, National Natural Science Foundation of China, Science Research Project of Hebei Education Department.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chemotherapy remains a major strategy for cancer treatment, with cisplatin widely used as a first‐line agent for diverse malignancies. Although cisplatin efficiently induces tumor cell death through DNA damage, its therapeutic efficacy is often limited by the development of an immunosuppressive tumor microenvironment that restricts effective immune activation. Here, we report a rationally engineered photosensitizer, CMPE, featuring efficient reactive oxygen species (ROS) generation and precise mitochondrial targeting. Upon spatially controlled light activation, CMPE induces mitochondrial oxidative stress and, in combination with cisplatin, triggers potent immunogenic cell death accompanied by robust release of damage‐associated molecular patterns that promote immune cell maturation and activation. In vivo, CMPE in combination with cisplatin enhances CD8 + T‐cell infiltration while reducing immunosuppressive cell populations, thereby converting immunologically “cold” tumors into an immune‐active phenotype and ultimately leading to significant tumor growth inhibition. Moreover, tumor cells pretreated with CMPE, either alone or combined with cisplatin, function as an effective whole‐cell vaccine that elicits durable immune memory and suppresses tumor recurrence. These findings demonstrate that a mitochondria‐targeted photosensitizer can serve as an effective platform for synergistic chemo‐photodynamic immunotherapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CisplatinPhotosensitizing AgentsMitochondriaAntineoplastic AgentsNeoplasmsAnimalsMiceReactive Oxygen SpeciesHumansCell Line, TumorCD8-Positive T-LymphocytesTumor MicroenvironmentImmunotherapyPhotochemotherapyOxidative StressMice, Inbred C57BL

Stichwörter der Autor:innen

DNA damagecancer researchimmune systemimmunogenic cell deathimmunotherapyphotosensitizerprogrammed cell deathtumor microenvironment

Substanzen

CisplatinPhotosensitizing AgentsReactive Oxygen SpeciesAntineoplastic Agents

Autor:innen und Institutionen

  • Department of Interventional Therapy, Peking University Cancer Hospital (Inner Mongolia Campus) & Affiliated Cancer Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, P. R. China.
  • Institute of Precision Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Sun Yat-Sen University, Guangzhou, P. R. China.
  • College of Life Sciences, Hebei Agricultural University, Baoding, P. R. China.
  • Department of Ultrasound Medicine, The Second Affiliated Hospital of Inner Mongolia Medical University, Hohhot, Inner Mongolia Autonomous Region, P. R. China.

ORCID-Profile: Duo Mao

Förderung

  • Inner Mongolia Natural Science Fund
  • National Natural Science Foundation of China
  • Science Research Project of Hebei Education Department

Zitieren

APA

Cui, W., Li, M., Bai, Q., He, N. S. M., Yao, S., An, Y., Li, E., Chen, X., Meng, Y., Wu, X., Mao, D., Wang, J., & Yu, H. (2026). A Robust Mitochondria‐Targeted Photosensitizer Synergizes With Cisplatin Chemotherapy for Enhanced Antitumor Immunity. Chemistry – A European Journal, 32(41). https://doi.org/10.1002/chem.71531

Vancouver

Cui W, Li M, Bai Q, He NSM, Yao S, An Y, et al. A Robust Mitochondria‐Targeted Photosensitizer Synergizes With Cisplatin Chemotherapy for Enhanced Antitumor Immunity. Chemistry – A European Journal. 2026;32(41). doi:10.1002/chem.71531

BibTeX
@article{Cui2026,
  author = {Cui, Wudama and Li, Min and Bai, Qingqing and He, Na Shun Meng and Yao, Shun and An, Yanhe and Li, Enyu and Chen, Xuebo and Meng, Yajun and Wu, Xinghua and Mao, Duo and Wang, Juan and Yu, Hai},
  title = {A Robust Mitochondria‐Targeted Photosensitizer Synergizes With Cisplatin Chemotherapy for Enhanced Antitumor Immunity},
  journal = {Chemistry – A European Journal},
  year = {2026},
  volume = {32},
  number = {41},
  doi = {10.1002/chem.71531}
}
Kostenlos starten →